Lobbying Filing Details

Total Spending

$150,000

Activities

3

Lobbyists

1

Gov't Entities

6

Filing Information
Filing UUID:
c144597a-66ae-4c95-bfc1-6f20817e59bf
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 09, 2026 at 8:41 PM
Income:
$0
Expenses:
$150,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
IONIS PHARMACEUTICALS, INC.
Carlsbad, California
Client
IONIS PHARMACEUTICALS, INC.

Biotechnology company.

California, United States of America
Lobbying Activities (3)
Activity 1
Health Issues

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.

Lobbyists (1)
  • JORDAN CHAPMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.

Lobbyists (1)
  • JORDAN CHAPMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Taxation/Internal Revenue Code

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Lobbyists (1)
  • JORDAN CHAPMAN
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.